Premier Path Wealth Partners’s Biogen BIIB Stock Holding History

Premier Path Wealth Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$466K	Sell	2,063 -723	-26%	-$153K	0.05%	272
2026 Q2	$602K	Sell	2,786 -737	-21%	-$141K	0.07%	234
2026 Q1	$646K	Sell	3,523 -2,207	-39%	-$407K	0.08%	221
2025 Q4	$1.01M	Sell	5,730 -3,313	-37%	-$541K	0.13%	157
2025 Q3	$1.27M	Sell	9,043 -508	-5%	-$68.7K	0.16%	137
2025 Q2	$1.2M	Buy	9,551 +839	+10%	+$105K	0.17%	149
2025 Q1	$1.19M	Buy	8,712 +1,156	+15%	+$165K	0.19%	138
2024 Q4	$1.16M	Buy	7,556 +1,548	+26%	+$261K	0.18%	140
2024 Q3	$1.16M	Buy	6,008 +341	+6%	+$71.3K	0.18%	141
2024 Q2	$1.31M	Buy	5,667 +392	+7%	+$85.2K	0.22%	109
2024 Q1	$1.14M	Buy	5,275 +1,450	+38%	+$340K	0.21%	125
2023 Q4	$1M	Buy	+3,825	New	+$939K	0.22%	117

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Premier Path Wealth Partners's BIIB Position: Q3 2026 in Review

Premier Path Wealth Partners reduced its Biogen (BIIB) stake by 26% in Q3 2026, selling an estimated $153K and leaving 2,063 shares worth $466K. The position accounts for 0.05% of the portfolio, ranked #272.

Premier Path Wealth Partners first reported a position in BIIB in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.31M in Q2 2024. 643 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

Premier Path Wealth Partners held 2,063 shares of Biogen worth $466K as of Q3 2026.
Premier Path Wealth Partners sold 723 Biogen shares in Q3 2026, an estimated $153K.
Biogen made up 0.05% of Premier Path Wealth Partners's portfolio in Q3 2026, its #272 holding.
Premier Path Wealth Partners first reported a position in Biogen in Q4 2023 and has held it in 12 quarters since.
Premier Path Wealth Partners's Biogen position peaked at $1.31M in Q2 2024.
643 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Premier Path Wealth Partners's 13F filing for Q3 2026, filed 16 Oct 2026.